Skip to main content

Table 3 Multivariate analysis of the factors associated with the first occurrence of VAP considering death, extubation and RIT as competing factors

From: Impact of dexamethasone on the incidence of ventilator-associated pneumonia and blood stream infections in COVID-19 patients requiring invasive mechanical ventilation: a multicenter retrospective study

 

CRH

95% CI

p value

Age

1.00

0.98–1.03

0.7

Comorbidities (0, 1, 2 or 3)

0.78

0.48–1.29

0.34

Dexamethasone use

1.07

0.65–1.77

0.79

SOFA score

0.98

0.99–1.02

0.48

Antibiotics at ICU admission

0.74

0.39

1.41

Time to intubation (days)

0.92

0.75–1.12

0.41

Duration of ICU stay (days)

1.01

1.02–1.08

0.09

  1. CRH competing risk hazard, CI confidence interval